Magnesium Bisglycinate Safety in Multiple Sclerosis
Magnesium bisglycinate is safe to take for patients with multiple sclerosis, including those on disease-modifying therapies, with no known contraindications or significant drug interactions with MS medications.
Safety Profile
The FDA-approved labeling for magnesium bisglycinate indicates only one contraindication: known hypersensitivity to any of the ingredients 1. There are no specific warnings against use in MS patients or interactions with disease-modifying therapies (DMTs).
Evidence Supporting Safety
Real-world use data demonstrates that magnesium supplementation is already widely used among MS patients:
- A 2020 cross-sectional study found that 75.8% of MS patients use natural medicines and dietary supplements concomitantly with conventional MS medicine 2
- Magnesium was among the most frequently combined products with conventional MS medications, alongside vitamin D, multivitamins, and calcium 2
- This widespread use pattern without reported safety concerns in the literature supports the safety profile
Potential Benefits in MS
While not the primary question, the evidence suggests possible therapeutic benefits:
- A 1986 study showed that dietary supplementation with calcium, magnesium, and vitamin D reduced MS exacerbation rates by more than half compared to case history controls, with no side effects reported 3
- A case report demonstrated significant improvement in spasticity in an MS patient treated with magnesium glycerophosphate, with no side effects or weakness 4
Important Considerations
Renal function is the primary safety concern:
- Magnesium supplements should be avoided in patients with creatinine clearance <20 mL/dL due to risk of hypermagnesemia 5
- In patients with normal renal function, systemic magnesium regulation is maintained through renal excretion 5
No interactions with MS disease-modifying therapies:
- The available guidelines on MS treatment monitoring 6 and DMT recommendations 7, 8 do not identify magnesium supplementation as a concern
- Standard MS pharmacovigilance focuses on opportunistic infections and disease activity, not mineral supplementation interactions
Practical Recommendations
- Check renal function before initiating magnesium supplementation in MS patients
- Standard dosing from FDA labeling is one tablet daily with food 1
- No special monitoring is required beyond routine MS care unless renal impairment is present
- Continue disease-modifying therapies without modification, as there are no known interactions
The only absolute contraindication is hypersensitivity to the ingredients 1 and significant renal impairment (CrCl <20 mL/dL).